[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News and Perspectives
July 26, 2006

“Polypill” Could Slash Diabetes Risks

JAMA. 2006;296(4):377-380. doi:10.1001/jama.296.4.377

Washington—A daily cocktail of inexpensive drugs for individuals with diabetes could save 1.2 million lives, prevent 4.5 million myocardial infarctions, reduce cases of renal failure by 600 000, and result in 1 million fewer cases of blindness or eye surgeries over the next 30 years, said Robert A. Rizza, MD, president of the American Diabetes Association (ADA) at the organization's annual meeting in June.

The proposal for a “polypill” treatment for patients with diabetes was one of a host of presentations at the conference addressing challenges in diabetes care. Physicians and scientists at the meeting emphasized the need to overcome “physician inertia” and encourage all clinicians to treat patients aggressively using the existing arsenal of treatment strategies. They also presented data on genes associated with diabetes, continuous glucose monitoring systems, and treating comorbidities in patients with diabetes or those at risk.

First Page Preview View Large
First page PDF preview
First page PDF preview
×